AMLX
Amylyx Pharmaceuticals, Inc.Healthcare$14.95
▲ Bullish
Mkt Cap: $1.65B|Float: 82.9M|SI: 16.7%|DTC: 14.7
Data as of market close Apr 2, 2026
IV Rank
85
IV Pctl
33%
HV 20d
47.7%
52W Range
$3-$17
ATR(14)
$0.75
Exp. Move
±3.5%
P/C Ratio
0.17
Earnings
May 7
GEX Positive
DEX Long
Net Call Premium
IV High
Max Pain Below
Exp. Move Moderate
Low Put/Call
AMLX Key Options Data
- IV Rank
- 85.3%
- Total GEX
- $0.00B
- Total DEX
- $0.4M
- Max Pain
- $13.00
- Expected Move
- ±3.5%
- Put/Call OI
- 0.17
- Net Premium
- $0.1M
- Spot Price
- $14.95
Gamma Exposure (GEX)
Delta Exposure (DEX)
Expected Move by Expiration
| Expiration | DTE | Expected Move | Move % | Lower | Upper |
|---|---|---|---|---|---|
| 2026-04-17 | 15 | ±$0.53 | ±3.5% | $14.42 | $15.47 |
| 2026-05-15 | 43 | ±$3.17 | ±21.2% | $11.77 | $18.12 |
| 2026-06-18 | 77 | ±$3.10 | ±20.7% | $11.85 | $18.05 |
| 2026-07-17 | 106 | ±$4.18 | ±27.9% | $10.77 | $19.12 |
| 2026-08-21 | 141 | ±$5.05 | ±33.8% | $9.90 | $20.00 |
| 2026-09-18 | 169 | ±$11.70 | ±78.3% | $3.25 | $26.65 |
Explore AMLX options data including implied volatility rankings, gamma and delta exposure, max pain levels, and expected price moves. AI-generated reports provide directional, income, and earnings analysis.